| 查看: 123 | 回复: 0 | |||
| 当前主题已经存档。 | |||
abcd888898银虫 (正式写手)
|
[交流]
【转帖】XOMA Reviews Priorities for 2010 and 2009 Accomplishments
|
||
|
XOMA Reviews Priorities for 2010 and 2009 Accomplishments BERKELEY, Calif., Jan 19, 2010 (GlobeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today provided a summary of its priorities for 2010 and accomplishments during 2009. "In 2009, we continued to advance our lead product candidate, XOMA 052, an antibody to interleukin-1 beta (IL-1 beta), into Phase 2 development as a potentially paradigm-shifting anti-inflammatory approach to the treatment of Type 2 diabetes and cardio-metabolic diseases," said Steven B. Engle, XOMA's Chairman and Chief Executive Officer. "Most significantly, we expanded the XOMA 052 program beyond our focus on diabetes to cardiovascular disease. This expansion was supported by results from our Phase 1 trials demonstrating benefit in biomarkers of cardiovascular disease, animal studies evaluating XOMA 052 in cardio-metabolic disease models, and studies with other IL-1 targeting agents that have shown the potential for cardiovascular benefit from IL-1 inhibition, some results of which are expected to be presented at the American College of Cardiology meeting in March." |
回复此楼» 猜你喜欢
求26届aidd博导推荐
已经有4人回复
-
关于SCI杂志发表挂名
已经有32人回复
-
药物学论文润色/翻译怎么收费?
已经有267人回复
-
2026申博推荐
已经有1人回复
-
一篇扩散模型的Nature Machine Intelligence论文和Elsevier上的深度学习药物书籍
已经有1人回复
-
中国药科大学2026入学博士，药物合成和设计经验，放射化学及放射医学研究
已经有25人回复
-
使用MolAICal进行多肽虚拟筛选教程-同样适用于蛋白质和核酸的虚拟筛选
已经有1人回复
-
使用MolAICal计算药物化学过滤器MCFs及MCE-18描述符
已经有0人回复
-
使用MolAICal发现蛋白受体潜在的活性口袋及位点
已经有0人回复